Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
11
×
clinical trials
11
×
deals
11
×
life sciences
national blog main
fda
national top stories
boston
investing
san francisco blog main
roche
san francisco top stories
amgen
new york blog main
new york top stories
rna interference
sanofi
startups
alexion pharmaceuticals
alnylam pharmaceuticals
alzheimer's disease
autoimmune disorders
biotech ipos
cancer
cancer drugs
cancer immunotherapy
covid-19
eli lilly
europe blog main
europe top stories
glaxosmithkline
ipo
kidney disease
national
novartis
regeneron pharmaceuticals
takeda pharmaceutical
venture capital
What
medicines
drug
new
research
biotech
disease
ipo
raised
therapeutics
alliance
cancer
candidate
company
days
deal
fda
gene
million
pact
pharma
pharmaceuticals
potential
roche
targets
team
treat
abbvie
acquire
address
adds
ago
agreed
allosteric
alternative
analytics
approval
arrival
autoimmune
billion
bio
Language
unset
11
×
Current search:
deals
×
" clinical trials "
×
unset
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma